TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING DEMAND FOR NATURAL AND HERBAL-BASED NANOMEDICINE
4.2.2 GROWING GERIATRIC POPULATION
4.3 RESTRAINTS
4.3.1 LACK OF AWARENESS ASSOCIATED WITH HERBAL NANOMEDICINE
4.4 OPPORTUNITY
4.4.1 ONGOING RESEARCH AND CLINICAL TRIALS ON HERBAL NANOMEDICINE
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE GLOBAL HERBAL NANOMEDICINE MARKET
5.3 TRENDS IN HERBAL NANOMEDICINES
5.3.1 BENEFITS OF NANOSIZING
5.3.2 COMBINATION THERAPY
5.3.3 SAFETY AND BIOCOMPATIBILITY
5.3.4 CLINICAL TRIALS AND COMMERCIALIZATION
6 GLOBAL HERBAL NANOMEDICINE MARKET, BY TYPE
6.1 OVERVIEW
6.2 POLYMERIC HERBAL NANOPARTICLES
6.3 SOLID LIPID NANOPARTICLES
6.4 PHYTOSOMES
6.5 NANO-MICELLES
6.6 SELF-NANO EMULSIFYING DRUG DELIVERY SYSTEM
6.7 NANOFIBERS
6.8 OTHERS
7 GLOBAL HERBAL NANOMEDICINE MARKET, BY SOURCE
7.1 OVERVIEW
7.2 GINSENG
7.3 TURMERIC
7.4 ALOE VERA
7.5 GINGER
7.6 OTHERS
8 GLOBAL HERBAL NANOMEDICINE MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 CANCER
8.3 CARDIOVASCULAR DISEASES
8.4 NEUROLOGICAL DISORDERS
8.5 OTHERS
9 GLOBAL HERBAL NANOMEDICINE MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 INDIA
9.4.3 JAPAN
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST & AFRICA
9.5.2 SOUTH AMERICA
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS, 2023
10.3 COMPETITOR DASHBOARD
10.4 PUBLIC PLAYERS STOCK SUMMARY
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
11 COMPANY PROFILES
11.1 EVOLU RESEARCH
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIES
11.2 CODEAGE LLC
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PROUDCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 NUTRIHERBS
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIES
11.4 BASIC BRANDS INC.
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 HERBALIFE INTERNATIONAL OF AMERICA, INC.
11.5.1 COMPANY OVERVIEW
11.5.2 FNANCIAL OVERVIEW
11.5.3 SERVICES OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 INDENA S.P.A
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 NANOCEUTICAL SOLUTIONS
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGY
11.8 VIBDRUGS BIOSCIENCES
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 ONE PLANET NUTRITION
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGY
11.10 OIC NEW
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES
12 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 3 GLOBAL HERBAL NANOMEDICINE MARKET, FOR POLYMERIC HERBAL NANOPARTICLES, BY REGION, 2019–2032 (USD BILLION)
TABLE 4 GLOBAL HERBAL NANOMEDICINE MARKET, FOR SOLID LIPID NANOPARTICLES, BY REGION, 2019–2032 (USD BILLION)
TABLE 5 GLOBAL HERBAL NANOMEDICINE MARKET, FOR PHYTOSOMES, BY REGION, 2019–2032 (USD BILLION)
TABLE 6 GLOBAL HERBAL NANOMEDICINE MARKET, FOR NANO-MICELLES, BY REGION, 2019–2032 (USD BILLION)
TABLE 7 GLOBAL HERBAL NANOMEDICINE MARKET, FOR SELF-NANO EMULSIFYING DRUG DELIVERY SYSTEM, BY REGION, 2019–2032 (USD BILLION)
TABLE 8 GLOBAL HERBAL NANOMEDICINE MARKET, FOR NANOFIBERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 9 GLOBAL HERBAL NANOMEDICINE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 10 GLOBAL HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 11 GLOBAL HERBAL NANOMEDICINE MARKET, FOR GINSENG, BY REGION, 2019–2032 (USD BILLION)
TABLE 12 GLOBAL HERBAL NANOMEDICINE MARKET, FOR TURMERIC, BY REGION, 2019–2032 (USD BILLION)
TABLE 13 GLOBAL HERBAL NANOMEDICINE MARKET, FOR ALOE VERA, BY REGION, 2019–2032 (USD BILLION)
TABLE 14 GLOBAL HERBAL NANOMEDICINE MARKET, FOR GINGER, BY REGION, 2019–2032 (USD BILLION)
TABLE 15 GLOBAL HERBAL NANOMEDICINE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 16 GLOBAL HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 17 GLOBAL HERBAL NANOMEDICINE MARKET, FOR CANCER, BY REGION, 2019–2032 (USD BILLION)
TABLE 18 GLOBAL HERBAL NANOMEDICINE MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2019–2032 (USD BILLION)
TABLE 19 GLOBAL HERBAL NANOMEDICINE MARKET, FOR NEUROLOGICAL DISORDERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 20 GLOBAL HERBAL NANOMEDICINE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 21 GLOBAL HERBAL NANOMEDICINE MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 22 NORTH AMERICA HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 23 NORTH AMERICA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 24 NORTH AMERICA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 25 NORTH AMERICA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 26 US: HERBAL NANOMEDICINE MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 27 US: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 28 US: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 29 CANADA: HERBAL NANOMEDICINE MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 30 CANADA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 31 CANADA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 32 EUROPE HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 33 EUROPE: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 34 EUROPE: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 35 EUROPE: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 36 GERMANY: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 37 GERMANY: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 38 GERMANY: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 39 FRANCE: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 40 FRANCE: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 41 FRANCE: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 42 UK: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 43 UK: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 44 UK: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 45 ITALY: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 46 ITALY: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 47 ITALY: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 48 SPAIN: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 49 SPAIN: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 50 SPAIN: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 51 REST OF EUROPE: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 52 REST OF EUROPE: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 53 REST OF EUROPE: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 54 ASIA-PACIFIC HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 55 ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 56 ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 57 ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 58 CHINA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 59 CHINA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 60 CHINA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 61 INDIA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 62 INDIA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 63 INDIA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 64 JAPAN: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 65 JAPAN: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 66 JAPAN: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 67 AUSTRALIA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 68 AUSTRALIA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 69 AUSTRALIA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 70 SOUTH KOREA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 71 SOUTH KOREA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 72 SOUTH KOREA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 73 REST OF ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 74 REST OF ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 75 REST OF ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 76 REST OF THE WORLD HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 77 REST OF THE WORLD: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 78 REST OF THE WORLD: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 79 REST OF THE WORLD: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 80 MIDDLE EAST & AFRICA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 81 MIDDLE EAST & AFRICA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 82 MIDDLE EAST & AFRICA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 83 SOUTH AMERICA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 84 SOUTH AMERICA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD BILLION)
TABLE 85 SOUTH AMERICA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 86 EVOLU RESEARCH: PRODUCTS OFFERED
TABLE 87 CODEAGE LLC: PRODUCT OFFERED
TABLE 88 NUTRIHERBS: PRODUCT OFFERED
TABLE 89 BASIC BRANDS INC.: PRODUCTS OFFERED
TABLE 90 HERBALIFE INTERNATIONAL OF AMERICA, INC.: PRODUCT OFFERED
TABLE 91 INDENA S.P.A. PRODUCTS OFFERED
TABLE 92 NANOCEUTICAL SOLUTIONS: PRODUCTS OFFERED
TABLE 93 VIBDRUGS BIOSCIENCES: PRODUCT OFFERED
TABLE 94 ONE PLANET NUTRITION: PRODUCTS OFFERED
TABLE 95 OIC NEW: PRODUCT OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL HERBAL NANOMEDICINE MARKET: STRUCTURE
FIGURE 2 GLOBAL HERBAL NANOMEDICINE MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL HERBAL NANOMEDICINE MARKET
FIGURE 6 GLOBAL HERBAL NANOMEDICINE MARKET, TYPE SEGMENT, 2023 & 2032 (USD BILLION)
FIGURE 7 GLOBAL HERBAL NANOMEDICINE MARKET, BY TYPE, 2023 & 2032 (USD BILLION)
FIGURE 8 GLOBAL HERBAL NANOMEDICINE MARKET SHARE (%), BY TYPE, 2023
FIGURE 9 GLOBAL HERBAL NANOMEDICINE MARKET, SOURCE SEGMENT, 2023 & 2032 (USD BILLION)
FIGURE 10 GLOBAL HERBAL NANOMEDICINE MARKET, BY SOURCE, 2023 & 2032 (USD BILLION)
FIGURE 11 GLOBAL HERBAL NANOMEDICINE MARKET SHARE (%), BY SOURCE, 2023
FIGURE 12 GLOBAL HERBAL NANOMEDICINE MARKET, APPLICATION SEGMENT, 2023 & 2032 (USD BILLION)
FIGURE 13 GLOBAL HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2023 & 2032 (USD BILLION)
FIGURE 14 GLOBAL HERBAL NANOMEDICINE MARKET SHARE (%), BY APPLICATION, 2023
FIGURE 15 GLOBAL HERBAL NANOMEDICINE MARKET, BY REGION, 2023 & 2032 (USD BILLION)
FIGURE 16 GLOBAL HERBAL NANOMEDICINE MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 17 NORTH AMERICA MARKET ANALYSIS: HERBAL NANOMEDICINE MARKET, 2019-2032 (USD BILLION)
FIGURE 18 NORTH AMERICA HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 19 NORTH AMERICA HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2023 (% SHARE)
FIGURE 20 EUROPE MARKET ANALYSIS: HERBAL NANOMEDICINE MARKET, 2019-2032 (USD BILLION)
FIGURE 21 EUROPE HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 22 EUROPE HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2023 (% SHARE)
FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: HERBAL NANOMEDICINE MARKET, 2019-2032 (USD BILLION)
FIGURE 24 ASIA-PACIFIC HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 25 ASIA-PACIFIC HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2023 (% SHARE)
FIGURE 26 REST OF THE WORLD MARKET ANALYSIS: HERBAL NANOMEDICINE MARKET, 2019-2032 (USD BILLION)
FIGURE 27 REST OF THE WORLD HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 28 REST OF THE WORLD HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2023 (% SHARE)
FIGURE 29 GLOBAL HERBAL NANOMEDICINE MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 30 COMPETITOR DASHBOARD: GLOBAL HERBAL NANOMEDICINE MARKET
FIGURE 31 CODEAGE LLC: SWOT ANALYSIS
FIGURE 32 HERBALIFE INTERNATIONAL OF AMERICA, INC.: FINANCIAL OVERVIEW
FIGURE 33 HERBALIFE INTERNATIONAL OF AMERICA, INC.: SWOT ANALYSIS
FIGURE 34 INDENA S.P.A.: SWOT ANALYSIS
FIGURE 35 ONE PLANET NUTRITION: SWOT ANALYSIS
FIGURE 36 OIC NEW: SWOT ANALYSIS
